Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis

NCT02071043 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Shanghai Zhongshan Hospital